Author:
Thrailkill Kathryn M.,Lumpkin Charles K.,Bunn R. Clay,Kemp Stephen F.,Fowlkes John L.
Abstract
Diabetic osteoporosis is increasingly recognized as a significant comorbidity of type 1 diabetes mellitus. In contrast, type 2 diabetes mellitus is more commonly associated with modest increases in bone mineral density for age. Despite this dichotomy, clinical, in vivo, and in vitro data uniformly support the concept that new bone formation as well as bone microarchitectural integrity are altered in the diabetic state, leading to an increased risk for fragility fracture and inadequate bone regeneration following injury. In this review, we examine the contribution that insulin, as a potential anabolic agent in bone, may make to the pathophysiology of diabetic bone disease. Specifically, we have assimilated human and animal data examining the effects of endogenous insulin production, exogenous insulin administration, insulin sensitivity, and insulin signaling on bone. In so doing, we present evidence that insulin, acting as an anabolic agent in bone, can preserve and increase bone density and bone strength, presumably through direct and/or indirect effects on bone formation.
Publisher
American Physiological Society
Subject
Physiology (medical),Physiology,Endocrinology, Diabetes and Metabolism
Reference144 articles.
1. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts
2. Estimated dietary calcium intake and food sources for adolescent females: 1980–92
3. Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, and Addar M.Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.Saudi Med J25: 1423–1427, 2004.
4. Nocturia, nocturnal polyuria, and sleep quality in the elderly
5. Bachrach LK.Dual-energy x-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls.J Pediatr Endocrinol Metab13,Suppl2: 983–988, 2000.
Cited by
408 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献